Given the significantly higher expression and positive correlation between YY1 and BIRC5/survivin observed in BLs, a model of aggressive B-NHL, the Raji BL cells have been selected for further validation at cellular and molecular levels. The gene discussed is BIRC5; the disease is Burkitt lymphoma.